Meet The Team
The people behind the science, strategy, and commercialization of next-gen wound care.
Sushant is a final-year PhD candidate in Mechanical Engineering at the University of Toronto with 7+ years of bioprinting experience. He leads commercialization at VRIT, working to launch the INSITE system into the market by 2040. As the driving force behind the technology’s development, he bridges deep technical expertise with strategic execution.
Sushant Singh
CEO, Co-Founder
Dr. Axel Guenther is a Professor at the University of Toronto and a global leader in bioprinting, known for pioneering several biofabrication technologies and co-founding the CRAFT research center in partnership with Canada’s NRC. A recipient of prestigious awards including the ETH Medal and U of T’s Innovator of the Year, his work bridges mechanical engineering and regenerative medicine.
Dr. Axel Guenther
CSO, Co-Founder
Avantika brings a cross-disciplinary background in cellular and biomaterials research, innovation consulting, and product development across nonprofit and startup settings. She holds an Honours Bachelor of Health Sciences from McMaster and a Master’s in Biomedical Engineering from the University of Toronto. At VRIT, she supports both R&D and commercialization to advance INSITE’s path to market.
Avantika Vaidya
R&D Associate
Jignesh Patel is a seasoned executive with over 20 years of experience driving innovation and product strategy in biologics, regenerative medicine, and medical devices. As Vice President at Smith+Nephew, he brings deep expertise in FDA-regulated product development, global R&D leadership, and commercial-scale product launches.
Jignesh Patel
Business Advisor
Dr. Marc Jeschke is a globally reknown burn surgeon and expert in translational burn research. Currently, he serves as Vice President, Research and Chief Scientific Officer at Hamilton Health Sciences. With decades of experience leading multidisciplinary teams, he has secured major national funding to advance stem cell-based skin regeneration and immunometabolic therapies for complex injuries.
Dr. Marc Jeschke
Clinical Advisor
Lee Johnson is a seasoned IP attorney and registered patent agent at Mintz, with deep expertise in biotech, medtech, and life sciences, advising clients on patent strategy, prosecution, and complex transactions. He has led IP efforts behind multiple biotech IPOs and acquisitions collectively exceeding $2 billion, and is a trusted advisor to startups, investors, and accelerators across North America.
Lee A. Johnson, PhD
IP Legal Counsel
-min.jpg)
-min.jpg)
